资料

如果您还有其他问题，请咨询您的医生。

如果您需要一个人来跟您讨论有关您对治疗费用的感觉和担忧，请要求和社工见面。

如果您需要更多有关肾衰竭的信息，请浏览以下网站：
1. HealthHub: https://www.healthhub.sg/a-z/diseases-and-conditions/kidney-failure

2. 全国肾脏基金会: https://www.nkfs.org/

3. 肾脏透析基金会: www.kdf.org.sg/
4. Ihsan Kidney Care: https://www.mtfa.org/ihsan-kidney-care
5. 国家疾病登记局: https://nrdo.gov.sg/publications/kidney-failure

myKIDNEY 团队

如需咨询此决策辅助工具的相关事宜，您可以发电邮联系我们：lcpc@duke-nus.edu.sg

引用: Ozdemir Semra, Choong Lina Hui Lin, Gan Sheryl Shien Wen, Choo Jason, Yee Alethea Chung Pheng, Lee Guozhang, Lim Lydia Wei Wei, Teo Boon Wee, Jafar Tazeen Hasan, Malhotra Chetna, Lee Jia Jia, Finkelstein Eric Andrew. myKIDNEY: 一个属于老年肾衰患者及其家属的决策辅助工具. 连氏慈怀研究中心: 新加坡 (2021).  https://www.duke-nus.edu.sg/lcpc/research/projects-(new)/interventional-studies/mykidney.

所有的作者没有任何利益冲突。

这个决策辅助工具的制作是由淡马锡基金会(2020-SMF-0007)、国家医学研究委员会(NMRC/HSRG/0080/2017)和连氏慈怀研究中心所赞助的。此研究已经获得了新加坡卫生伦理审查委员会(2021/2143) 的批准。

我们感谢以下人士和团体参与了这个决策辅助工具的制作并给予了支持：

• 新加坡中央医院肾脏内科
• 国立大学医院肾脏科
• 全国疾病登记署
• 全国肾脏基金会
• RETREAT 研究团队
• RETREAT 顾问小组

文献

1. Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. Retrieved from https://www.usrds.org/2018/view/v2_01.aspx
2. Seow, Y., Cheung, Y. B., Qu, L. M., & Yee, A. C. (2013). Trajectory of Quality of Life for Poor Prognosis Stage 5D Chronic Kidney Disease with and without Dialysis. American Journal of Nephrology,37(3), 231-238. doi:10.1159/000347220
3. National Registry of Diseases Office, Health Promotion Board

这本手册的制作引用了以下文献:

4. Singapore Renal Registry Annual Report 2016 - NRDO. Retrieved from https://www.nrdo.gov.sg/docs/librariesprovider3/default-document-library/singapore-renal-registry-annual-report-2016_1999-till-2016_v5_online_final.pdf?sfvrsn=0
5. Carson, R. C., Juszczak, M., Davenport, A., & Burns, A. (2009). Is Maximum Conservative Management an Equivalent Treatment Option to Dialysis for Elderly Patients with Significant Comorbid Disease? Clinical Journal of the American Society of Nephrology,4(10), 1611-1619. doi:10.2215/cjn.00510109
6. De Biase V, Tobaldini O, Boaretti C, et al. Prolonged conservative treatment for frail elderly patients with end-stage renal disease: the Verona experience. Nephrol Dial Transplant. 2008; 23(4):1313–1317. doi:10.1093/ndt/gfm772
7. Silva-Gane, M. D., Wellsted, D., Greenshields, H., Norton, S., Chandna, S. M., & Farrington, K. (2012). Quality of Life and Survival in Patients with Advanced Kidney Failure Managed Conservatively or by Dialysis. Clinical Journal of the American Society of Nephrology, 7(12), 2002-2009. doi:10.2215/cjn.01130112
8. Thorsteinsdottir, B., Murad, M. H., Montori, V., & Prokop. (2013). Ageism vs the technical imperative applying the GRADE framework to the evidence on hemodialysis in very elderly patients. Clinical Interventions in Aging, 797. doi:10.2147/cia.s43817
9. Seow, Y., Cheung, Y. B., Qu, L. M., & Yee, A. C. (2013). Trajectory of Quality of Life for Poor Prognosis Stage 5D Chronic Kidney Disease with and without Dialysis. American Journal of Nephrology, 37(3), 231-238. doi:10.1159/000347220
10. Murtagh, F. E., Addington-Hall, J. M., & Higginson, I. J. (2011). End-Stage Renal Disease: A New Trajectory of Functional Decline in the Last Year of Life. Journal of the American Geriatrics Society, 59(2), 304-308. doi:10.1111/j.1532-5415.2010.03248.x
11. Tan Tock Seng Hospital, Ministry Of Health, Dialysis Counselling Booklet Kidney Research UK, Dialysis: making the right choices for you
12. Murtagh, F. E., Marsh, J. E., Donohoe, P., Ekbal, N. J., Sheerin, N. S., & Harris, F. E. (2007). Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrology Dialysis Transplantation, 22(7), 1955-1962. doi:10.1093/ndt/gfm153
13. Chandna, S. M., Silva-Gane, M. D., Marshall, C., Warwicker, P., Greenwood, R. N., & Farrington, K. (2010). Survival of elderly patients with stage 5 CKD: Comparison of conservative management and renal replacem-ent therapy. Nephrology Dialysis Transplantation, 26(5), 1608- 1614. doi:10.1093/ndt/gfq630